Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features

  • Enjuanes, Anna|||0000-0002-4679-6687
  • Albero Gallego, Robert|||0000-0001-5527-0997
  • Clot, Guillem|||0000-0003-2588-7413
  • Navarro, Alba|||0000-0002-4041-0974
  • Bea, Sílvia|||0000-0001-7192-2385
  • Pinyol, Magda
  • Martin-Subero, Jose Ignacio|||0000-0001-8809-5195
  • Klapper, Wolfram|||0000-0001-7208-4117
  • Staudt, L.M.
  • Jaffe, E.S.
  • Rimsza, L.M.
  • Braziel, Rita M
  • Delabie, Jan
  • Cook, James R.
  • Tubbs, R.S.
  • Gascoyne, Randy
  • Connors, Joseph M
  • Weisenburger, Dennis D
  • Greiner, Timothy C
  • Chan, Wing-Chung
  • López Guillermo, Armando|||0000-0002-8588-8381
  • Rosenwald, Andreas|||0000-0001-7282-8374
  • Ott, German|||0000-0001-7990-6793
  • Campo, Elias|||0000-0001-9850-9793
  • Jares, Pedro
Mantle cell lymphoma (MCL) is a B-cell neoplasm with an aggressive clinical behavior characterized by the t(11;14)(q13;q32) and cyclin D1 overexpression. To clarify the potential contribution of altered DNA methylation in the development and/or progression of MCL, we performed genome-wide methylation profiling of a large cohort of primary MCL tumors (n = 132), MCL cell lines (n = 6) and normal lymphoid tissue samples (n = 31), using the Infinium HumanMethylation27 BeadChip. DNA methylation was compared to gene expression, chromosomal alterations and clinicopathological parameters. Primary MCL displayed a heterogeneous methylation pattern dominated by DNA hypomethylation when compared to normal lymphoid samples. A total of 454 hypermethylated and 875 hypomethylated genes were identified as differentially methylated in at least 10% of primary MCL. Annotation analysis of hypermethylated genes recognized WNT pathway inhibitors and several tumor suppressor genes as frequently methylated, and a substantial fraction of these genes (22%) showed a significant downregulation of their transcriptional levels. Furthermore, we identified a subset of tumors with extensive CpG methylation that had an increased proliferation signature, higher number of chromosomal alterations and poor prognosis. Our results suggest that a subset of MCL displays a dysregulation of DNA methylation characterized by the accumulation of CpG hypermethylation highly associated with increased proliferation that may influence the clinical behavior of the tumors.